---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-019789"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2026-06-08T12:00:11+00:00"
generated_at: "2026-06-08T12:05:48.841992+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BioCardia raises $4.4M via ATM share sale, extends cash runway into Q1 2027

## Summary
- Sold 3,509,604 shares at average $1.279 on June 5, 2026; net proceeds ~$4.4M.
- Proceeds expected to extend cash runway into Q1 2027, beyond planned Japan PMDA submission.
- If outstanding warrants from prior financings exercised for cash, runway would extend beyond PMDA approval into first commercial sales.
- No warrants were issued in this capital raise.

## SEC filing metadata
- accession: 0001437749-26-019789
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2026-06-08T12:00:11+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774926019789/0001437749-26-019789-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774926019789/bcda20260607_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-019789
- JSON: https://secwatch.observer/filing/0001437749-26-019789.json
- Plain text: https://secwatch.observer/filing/0001437749-26-019789.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.